Skip to main content

Table 2 QPCR results of verification group 1

From: Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes

Gene Cytoband t-test Sign. FC Earlier suggested by
ACD 16q22.1 0.1029 n.s. 4  
ACP1 2p25 0.0023 ** 4  
ATBF1 16q22.3 1.70E-05 *** 9  
BRSK2 11p15.5 2.40E-04 *** 21  
C2orf25 2q23.3 0.0929 n.s. 3  
C5orf13 5q22.1 0.0102 * 4  
CACNA2D3 3p21.1 0.0019 ** 133 [31]
CBFB 16q22.1 2.04E-05 *** 9  
CCND1 11q13 0.0012 ** 6  
CDC5L 6p21 0.0072 ** 15  
CHCHD2 7p11.2 0.0041 ** 4  
CLASP1 2q14.2-q14.3 0.0021 ** 12  
CNTNAP2 7q35-q36 0.0011 ** 287  
CXXC4 4q24 0.0350 * 10  
DBH 9q34 0.0039 ** 15 [15, 32]
DCUN1D2 13q34 0.0027 ** 26  
DCX Xq22.3-q23 0.0091 ** 9  
DDC 7p11 0.0156 * 24 [32, 33]
DGUOK 2p13 0.0047 ** 10  
DPYSL3 5q32 0.0100 ** 23 [33]
EIF2S3 Xp22.11 0.0024 ** 4  
FLJ20323 7p21.3 0.0015 ** 10  
FSCN1 7p22 0.0091 ** 4  
FSD1 19p13.3 0.0077 ** 8  
FUS 16p11.2 0.0350 * 15  
FUSIP1 1p36.11 0.0128 * 22  
GATA2 3q21.3 0.0260 * 4 [32]
GATA3 10p15 0.0018 ** 6 [15]
GDF1; LASS1 19p12 0.0409 * 10  
GNB1 1p36.33 0.0028 ** 10 [15, 32]
H3F3B 1q41 0.0057 ** 4  
HDAC2 6q21 0.0036 ** 11  
HNRPDL 4q21.22 0.0025 ** 7  
HNRPH3 10q22 0.0086 ** 7  
IDH2 15q26.1 0.0023 ** 6  
ILF2 1q21.3 0.0161 * 6  
ISL1 5q11.2 0.0074 ** 6  
ITGAE 17p13 n.d. n.d. n.d.  
KIAA0408 6q22.33 3.96E-04 *** 15  
KIDINS220 2p24 0.0014 ** 15  
LOC440434 17q12 0.0264 * 11  
MAOA Xp11.3 0.0105 * 12  
MARCKSL1 1p35.1 0.0107 * 5  
MCM6 2q21 0.0301 * 5  
MCG12760 1p36.13 n.d. n.d. n.d.  
MCG4655 16q22.1 0.3849 n.s. 1  
MTF2 1p22.1 7.83E-04 *** 10  
NACA 12q13.3 0.0240 * 4  
NDUFS4 5q11.1 5.06E-04 *** 5  
NONO Xq13.1 0.0015 ** 6  
NSUN6 10p12.31 0.0010 *** 20  
PAFAH1B3 19q13.1 0.0044 ** 8  
PALM 19p13.3 2.28E-04 *** 7  
PHOX2A 11q13.2 0.0223 * 26  
PHOX2B 4p12 0.0042 ** 18 [15]
PILRB 7q22.1 0.0084 ** 15  
PKIA 8q21.11 8.69E-04 *** 21  
POU2F1 1q24.1-24.2 5.77E-04 *** 20  
POU4F2 4q31.2 0.0106 * 1518 [18, 34]
PRKRA 2q31.2 0.0042 ** 18  
RABL2B; RABL2A 2q13 0.0122 * 17  
RAPGEF6 5q23.3 0.0097 ** 37 [35]
REV1L 2q11.2 8.99E-04 *** 9  
RPL19 17q12 0.1034 n.s. 2  
SEC61G 7p11.2 0.0140 * 7  
SEPHS1 10p14 4.51E-04 *** 6  
SFRS3 6p21 0.0126 * 5  
SHC1 1q21 0.0129 * 12  
SLC18A1 8p21.3 0.0130 * 25  
SLC35E2 1p36.33 0.0241 * 3 [15]
SLC6A2 16q12.2 0.0012 ** 540  
SMN1; SMN2 5q13 0.0104 * 8  
SMPD4 2q21.1 0.0279 * 6  
SPAST 2p22.3 2.48E-05 *** 9  
ST13 22q13.2 0.0324 * 5  
TAF9B Xq21.1 0.0243 * 7  
TCP1 6q25.3 2.89E-04 *** 6  
TFAP2B 6p12.3 0.0115 * 13 [14, 31, 33, 34]
TH 11p15.5 0.0126 * 11 [15, 32]
TIA1 2p14 5.99E-05 *** 16  
TMSL8 Xq22.1 0.2105 n.s. 2  
TNFRSF25 1p36.31 0.0717 n.s. 8 [15, 33, 36]
TOP2B 3p24.2 2.49E-04 *** 4  
TPRKB 2p13.2 0.0386 * 4  
UBE2E3 2q31.3 0.0110 * 13  
UCKL1 20q13.33 0.0013 ** 11  
VPS28 8q24.3 0.0090 ** 9  
XRCC5 2q35 0.0092 ** 7  
YWHAQ 2p25.1 0.0400 * 5  
  1. Ver 1 = verification group 1; Cytoband = Chromosomal location; t-test = significance by Student's t-test; n.d. = not determined; Sign. = Significance level by Student's t-test, * p < 0,05, ** p < 0,01, *** p < 0,001, n.s. = not significant; FC = Fold change between groups. Transcripts selected for the second verification are highlighted in bold.